CS868887A2 - Method of quinoline carboxylic acids production - Google Patents

Method of quinoline carboxylic acids production

Info

Publication number
CS868887A2
CS868887A2 CS878688A CS868887A CS868887A2 CS 868887 A2 CS868887 A2 CS 868887A2 CS 878688 A CS878688 A CS 878688A CS 868887 A CS868887 A CS 868887A CS 868887 A2 CS868887 A2 CS 868887A2
Authority
CS
Czechoslovakia
Prior art keywords
carboxylic acids
quinoline carboxylic
acids production
production
agents
Prior art date
Application number
CS878688A
Other languages
English (en)
Other versions
CS270577B2 (en
Inventor
Michael Dr Preiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CS868887A2 publication Critical patent/CS868887A2/cs
Publication of CS270577B2 publication Critical patent/CS270577B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
CS878688A 1986-12-03 1987-11-30 Method of quinoline carboxylic acids production CS270577B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863641312 DE3641312A1 (de) 1986-12-03 1986-12-03 Verfahren zur herstellung von chinolincarbonsaeuren

Publications (2)

Publication Number Publication Date
CS868887A2 true CS868887A2 (en) 1989-11-14
CS270577B2 CS270577B2 (en) 1990-07-12

Family

ID=6315377

Family Applications (1)

Application Number Title Priority Date Filing Date
CS878688A CS270577B2 (en) 1986-12-03 1987-11-30 Method of quinoline carboxylic acids production

Country Status (25)

Country Link
EP (1) EP0274033B1 (cs)
JP (1) JPS63145268A (cs)
KR (1) KR970005191B1 (cs)
CN (1) CN87107230A (cs)
AT (1) ATE73446T1 (cs)
AU (1) AU593961B2 (cs)
CS (1) CS270577B2 (cs)
DD (1) DD270904A5 (cs)
DE (2) DE3641312A1 (cs)
DK (1) DK174929B1 (cs)
ES (1) ES2038156T3 (cs)
FI (1) FI875289A7 (cs)
GR (1) GR3004301T3 (cs)
HU (1) HU199823B (cs)
IE (1) IE64261B1 (cs)
IL (1) IL84627A (cs)
NO (1) NO174199C (cs)
NZ (1) NZ222736A (cs)
PH (1) PH24489A (cs)
PL (1) PL158614B1 (cs)
PT (1) PT86252B (cs)
SU (1) SU1482526A3 (cs)
UA (1) UA8017A1 (cs)
YU (1) YU45049B (cs)
ZA (1) ZA879040B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (cs) * 1985-09-18 1990-05-05 Pfizer
WO1990013542A1 (en) * 1989-04-28 1990-11-15 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
ES2050613B1 (es) * 1992-10-16 1996-03-16 Iteve S A Nuevo procedimiento para la preparacion de derivados del acido 1-ciclopropil-3-quinolincarboxilico.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
AU6421898A (en) * 1997-03-25 1998-10-20 Sankyo Company Limited Anti-fiv agent
KR100454750B1 (ko) * 2002-06-20 2004-11-03 삼성에스디아이 주식회사 유기 전계 발광 소자용 청색 발광 화합물 및 이를 사용한유기 전계 발광 소자
CA2536429C (en) 2003-09-10 2012-02-14 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN101671302B (zh) * 2008-12-30 2011-03-30 广东海康兽药有限公司 禽畜用抗菌药恩诺沙星的生产工艺
CN101899044B (zh) * 2010-08-16 2012-07-18 常州市勇毅生物药业有限公司 吉米沙星主环化合物的合成方法
CN113912540A (zh) * 2021-12-15 2022-01-11 山东国邦药业有限公司 一种1-环丙基-6,7-二氟-1,4-二氢-4-氧代-3-喹啉甲酸的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5365887A (en) * 1976-11-22 1978-06-12 Kyorin Seiyaku Kk Substituted quinoline*arboxylate and process for preparing same
DE2656574A1 (de) * 1976-12-10 1978-06-15 Schering Ag Neue 1,6-naphthyridincarbonsaeurederivate und verfahren zu ihrer herstellung
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
IL74244A (en) * 1984-02-17 1988-06-30 Warner Lambert Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS61205258A (ja) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法

Also Published As

Publication number Publication date
DE3641312A1 (de) 1988-06-09
NO874788D0 (no) 1987-11-17
KR970005191B1 (ko) 1997-04-14
NZ222736A (en) 1990-08-28
NO174199B (no) 1993-12-20
AU8217787A (en) 1988-06-09
PT86252A (en) 1988-01-01
PT86252B (pt) 1990-11-07
FI875289A7 (fi) 1988-06-04
HUT45521A (en) 1988-07-28
AU593961B2 (en) 1990-02-22
ATE73446T1 (de) 1992-03-15
NO874788L (no) 1988-06-06
KR880007472A (ko) 1988-08-27
IE64261B1 (en) 1995-07-26
PL269185A1 (en) 1989-01-05
CN87107230A (zh) 1988-07-06
FI875289A0 (fi) 1987-12-01
DK633187D0 (da) 1987-12-02
DE3777370D1 (de) 1992-04-16
ZA879040B (en) 1988-05-26
CS270577B2 (en) 1990-07-12
EP0274033A1 (de) 1988-07-13
PH24489A (en) 1990-07-18
SU1482526A3 (ru) 1989-05-23
ES2038156T3 (es) 1993-07-16
IL84627A (en) 1992-01-15
JPS63145268A (ja) 1988-06-17
DK174929B1 (da) 2004-03-01
HU199823B (en) 1990-03-28
NO174199C (no) 1994-04-06
DD270904A5 (de) 1989-08-16
DK633187A (da) 1988-06-04
PL158614B1 (pl) 1992-09-30
UA8017A1 (uk) 1995-12-26
EP0274033B1 (de) 1992-03-11
IL84627A0 (en) 1988-04-29
YU45049B (en) 1991-06-30
YU215687A (en) 1988-10-31
IE873279L (en) 1988-06-03
GR3004301T3 (cs) 1993-03-31

Similar Documents

Publication Publication Date Title
CS868887A2 (en) Method of quinoline carboxylic acids production
NO942468D0 (no) Fremgangsmåte for fremstilling av 2-alkyl-3,4,6-trifluorbenzoesyre
PH23256A (en) A process for the preparation of quinolone carboxylic acid derivatives
EP0287926A3 (en) Process for the preparation of quinoline carboxylic acids for parenteral application
GR3019796T3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
PL295331A1 (en) Method of obtaining novel derivatives of quinolonocarboxylic acid
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
HU912169D0 (en) Process for the production of 3,3'-ditio-bis(propionic acid)-derivatives and esthers, and medical preparations containing them
EP0288758A3 (en) Dihydropyridinamides, process for their preparation and their use in medicines
AU638437B2 (en) Substituted azetidinylpyridonecarboxylic acid derivatives, their preparation and their application as medicinal products
HU9302778D0 (en) Process for preparing acyl-sulfonamido-and sulfonamido-pyridine-2-carboxylic acid esters and pharmaceutical compositions containing them
MA21434A1 (fr) Procede de preparation de derives thieno-imidazole substitues utilisables comme inhibiteurs de la secretion d'acidite gastrique.

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20071130